No topic in men’s health generates more misinformation than testosterone replacement therapy. The fear-based narrative has been built over decades from flawed studies, outdated hypotheses, and cultural discomfort with the idea that men’s hormonal health might actually matter and be worth treating.

The result is a landscape where men who genuinely need TRT avoid it because of concerns that don’t hold up to scrutiny — and men who do pursue it do so with a distorted picture of what the real risks and real benefits actually are.

This issue covers the full myth landscape. Some of these are pure fiction. Some are half-truths that need context. And a few are legitimate concerns that have been dramatically overstated. All of them deserve an honest answer.

The Quick Dismissals

These myths require minimal treatment because the evidence against them is clear and consistent.

TRT is only for old men: Testosterone decline begins in a man’s late 20s and accelerates through his 30s and 40s. Age is not the qualifier. Labs and symptoms together are.

TRT is the same as anabolic steroid abuse: Therapeutic TRT restores testosterone to a physiologically normal range. Anabolic steroid abuse involves supraphysiological doses — often 5 to 10 times higher — for performance enhancement. These are not the same thing in mechanism, dose, intent, or risk profile.

You have to cycle TRT like steroids: TRT is not cycled. It is a continuous hormonal replacement protocol. The cycling concept comes from anabolic steroid use and does not apply.

TRT is addictive: The body does not become addicted to testosterone. It becomes dependent on exogenous testosterone when natural production is suppressed — which is a physiological adaptation, not addiction. Men who discontinue TRT with proper protocol can restore natural production over time.

TRT will make you muscular without training: Testosterone supports muscle protein synthesis. It does not build muscle on its own. A man on TRT who does not train will not become muscular. Training remains non-negotiable.

TRT causes rage and aggression: Addressed in full below under the E2 section — this one deserves more than a dismissal.

TRT is experimental and not well studied: Testosterone has been used therapeutically for over 80 years. The research base is extensive. The TRAVERSE trial alone — a large randomized controlled trial specifically designed to assess cardiovascular safety — enrolled over 5,000 men. This is not a fringe intervention.

The Myths That Need Full Treatment

1. TRT Causes Prostate Cancer

This is the most persistent and most damaging TRT myth — and the one most responsible for men avoiding a therapy that could meaningfully improve their quality of life.

The fear originates from research conducted in the 1940s by Charles Huggins, who found that castration (eliminating testosterone) slowed prostate cancer progression, and that testosterone administration accelerated it in men with existing cancer. From this observation came the assumption that testosterone fuels prostate cancer growth — an assumption that dominated urology for decades.

The problem is that more rigorous modern research has not supported this hypothesis for men without existing prostate cancer. The saturation model — developed by Dr. Abraham Morgentaler, one of the leading researchers in this area — proposes that prostate tissue has a saturation point for androgens beyond which additional testosterone produces no further stimulation. Men with low testosterone who bring their levels into the normal physiological range are not increasing prostate cancer risk. They are moving within a range the prostate has always been designed to function in.

Multiple large studies and meta-analyses have failed to demonstrate a causal link between TRT and increased prostate cancer incidence in men without pre-existing disease. The honest caveat: TRT can stimulate existing prostate tissue, which is why PSA baseline and monitoring is non-negotiable for men on TRT. A trend in PSA over time matters. But starting TRT does not cause prostate cancer in a healthy prostate.

2. TRT Causes Heart Attacks and Strokes

This concern has more legitimate history than the prostate cancer myth and deserves honest treatment rather than simple dismissal.

Early observational studies — particularly a 2010 study in the New England Journal of Medicine and a 2013 study in JAMA — suggested increased cardiovascular risk with TRT use. These studies generated significant alarm and led to FDA label warnings that persist today. The problem is that both studies had significant methodological limitations and the research community has largely moved past them.

The TRAVERSE trial — the largest and most rigorous randomized controlled trial specifically designed to assess TRT cardiovascular safety — was published in 2023 and enrolled over 5,000 men with hypogonadism and elevated cardiovascular risk. The finding: TRT did not increase the rate of major cardiovascular events compared to placebo. For men with low testosterone, restoring levels to the normal range was not associated with increased heart attack or stroke risk.

The honest nuance: hematocrit elevation — increased red blood cell production — is a real and manageable TRT effect that requires monitoring. Significantly elevated hematocrit increases blood viscosity and theoretically clotting risk. This is why hematocrit is part of the standard TRT monitoring panel and why therapeutic phlebotomy is sometimes used to manage it. It is a real consideration, not a reason to avoid TRT — it is a reason to monitor properly.

3. TRT Causes Hair Loss

This one sits in the half-truth category and deserves honesty rather than dismissal.

Male pattern baldness — androgenetic alopecia — is driven by dihydrotestosterone (DHT), a potent androgen converted from testosterone by the enzyme 5-alpha reductase. TRT increases testosterone, which provides more substrate for DHT conversion, which can accelerate hair loss in men who are genetically predisposed to it.

The key phrase is genetically predisposed. A man with no family history of male pattern baldness and no existing hair thinning is at minimal risk. A man who is already losing hair or has significant family history on both sides is at real risk of acceleration. TRT does not cause hair loss in men who were never going to experience it. It can accelerate a process that was already written into the genetics.

This is one of the few TRT concerns worth taking seriously as a personal consideration — not as a reason to avoid TRT, but as a factor to discuss with your provider and weigh against the benefits of hormonal optimization.

4. TRT Permanently Destroys Fertility

TRT alone does significantly suppress fertility — that part is true and important. Exogenous testosterone suppresses LH and FSH, which are the signals that drive sperm production. A man on TRT without HCG will see significant reductions in sperm count, sometimes to near zero.

What the myth gets wrong is the word permanently. For most men, fertility can be preserved on TRT with the right protocol — specifically HCG, which mimics LH and maintains testicular function and sperm production alongside exogenous testosterone. Men who want to preserve fertility potential while on TRT have a clear path to do so.

For men who discontinue TRT entirely, natural testosterone production and fertility typically recover — though the timeline varies and is not guaranteed for every man, particularly after long-term use. This is not a reason to avoid TRT. It is a reason to include HCG from day one and to have an honest conversation with your provider about your fertility goals before starting.

The Real Culprit: Mismanaged Estradiol

A significant portion of the negative effects attributed to testosterone are not testosterone effects at all. They are estradiol management failures — and the distinction matters enormously for how men understand and approach TRT.

When exogenous testosterone is introduced, some of it aromatizes to estradiol. In a well-managed protocol, this is monitored and addressed symptom-by-symptom. In a poorly managed protocol — or in the anabolic steroid abuse context where doses are supraphysiological — estradiol climbs unchecked and produces a predictable set of effects that get wrongly attributed to testosterone.

Rage and aggression: The “roid rage” narrative is almost entirely an estradiol story. Chronically elevated E2 in men produces emotional volatility, irritability, and mood instability that has nothing to do with testosterone directly. Men on well-managed TRT with appropriate E2 levels do not become aggressive. Men running supraphysiological doses with no E2 management do — and the testosterone gets the blame.

Acne: Androgenic acne can occur with TRT, but severe acne is more commonly associated with elevated estradiol and the hormonal imbalance of a poorly managed protocol than with testosterone itself. Men with well-managed E2 on appropriate TRT doses rarely experience significant acne.

Gynecomastia: Breast tissue development in men is driven by elevated estradiol, not testosterone. A man whose E2 is managed appropriately is at minimal risk. A man running elevated E2 unchecked — particularly at higher doses — is at real risk. The fix is E2 management, not testosterone avoidance.

Water retention and the puffy look: The bloated, soft appearance associated with steroid users is an E2 effect. Appropriate TRT doses with managed E2 do not produce this. It is a protocol failure, not a testosterone effect.

Most of what men fear about TRT is not a testosterone problem. It is an estradiol management problem. The solution is a well-run protocol — not avoidance.

The Cheating Charge: The Weakest Argument Against TRT

The idea that TRT is somehow cheating — that men who optimize their hormones are taking a shortcut that undermines the integrity of their results — deserves to be addressed directly because it is the argument most likely to come from people who should know better.

Consider how men optimize in every other domain of their lives without moral objection. When traffic is bad, you take the toll lane. When you go to Disney with your family, you get the fast pass. When you’re sick and it warrants it, you take the antibiotic. Nobody argues you should sit in traffic on principle when the toll lane is available. Nobody says the fast pass is cheating at Disney. Nobody tells a man with a bacterial infection to let his immune system handle it without help because that’s the authentic experience.

Men optimize their careers, their finances, their relationships, their tools, and their environment constantly and without apology. The idea that hormonal health — one of the most fundamental variables in a man’s energy, mood, performance, and quality of life — should be left to decline without intervention because optimization is somehow inauthentic is not a serious position. It is a double standard that exists nowhere else in how men approach their lives.

TRT for a man with genuinely low testosterone is not a shortcut. It is restoring a physiological variable to the range his body was designed to operate in. The work still has to be done. The Foundation still has to be built. The training, nutrition, sleep, and discipline that produce results are still required. TRT amplifies a system that is already functioning. It does not replace the work.

The Bottom Line

TRT is not without considerations — PSA monitoring, hematocrit management, E2 oversight, and HCG inclusion are all real and important parts of a responsible protocol. But the fear-based narrative that has kept men away from a legitimate and well-studied therapy is built on outdated science, methodologically flawed studies, and cultural discomfort rather than current evidence.

The man who avoids TRT because he’s heard it causes prostate cancer, destroys the heart, or represents some kind of moral failing is making a decision based on a version of the science that has largely been revised. Get current. Get evaluated. And if TRT is the right call based on your labs and your symptoms, make the decision with accurate information rather than inherited fear.

THE TEMPERED MAN